D.E. Shaw & Co’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-63,547
Closed -$1.33M 5570
2022
Q3
$1.33M Sell
63,547
-238,534
-79% -$4.97M ﹤0.01% 3365
2022
Q2
$6.27M Sell
302,081
-827,853
-73% -$14.7M 0.01% 1862
2022
Q1
$19M Buy
1,129,934
+101,199
+10% +$1.77M 0.02% 1069
2021
Q4
$20.5M Buy
1,028,735
+479,008
+87% +$9.02M 0.02% 1073
2021
Q3
$9.97M Buy
549,727
+516,968
+1,578% +$11.9M 0.01% 1527
2021
Q2
$884K Buy
32,759
+20,917
+177% +$585K ﹤0.01% 3639
2021
Q1
$355K Sell
11,842
-56,735
-83% -$1.93M ﹤0.01% 3647
2020
Q4
$1.97M Buy
68,577
+19,224
+39% +$519K ﹤0.01% 2564
2020
Q3
$1.2M Buy
49,353
+7,187
+17% +$155K ﹤0.01% 2745
2020
Q2
$754K Buy
42,166
+11,669
+38% +$153K ﹤0.01% 3117
2020
Q1
$248K Buy
30,497
+2,696
+10% +$30.8K ﹤0.01% 3562
2019
Q4
$367K Sell
27,801
-22,119
-44% -$268K ﹤0.01% 3545
2019
Q3
$594K Sell
49,920
-30,116
-38% -$557K ﹤0.01% 3129
2019
Q2
$1.96M Sell
80,036
-25,821
-24% -$744K ﹤0.01% 2253
2019
Q1
$3.37M Buy
+105,857
New +$3.76M ﹤0.01% 1802

Other funds holding CVET

D.E. Shaw & Co's CVET Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 63,547 shares — an estimated $1.33M sold.

D.E. Shaw & Co first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $20.5M in Q4 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 63,547 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $1.33M.
  • D.E. Shaw & Co first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • D.E. Shaw & Co's Covetrus, Inc. Common Stock position peaked at $20.5M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.